 doxorubicin cisplatin treatment adrenal cortical carcinoma Fourteen patients progressive metastatic adrenal cortical carcinoma combination doxorubicin cisplatin FAP large tumor burden patients hormone-producing tumor treatment chemotherapy possible antihormonal effects Treatment patients overall response rate confidence interval CI complete remission months patient Partial remissions months patients Cardiotoxicity patients myelotoxicity nephrotoxicity regimen active combination treatment metastatic adrenal cortical carcinoma